DolCas Biotech to showcase Curcugen chocolate prototype at Vitafoods Europe 2024
DolCas Biotech has announced that it will be showcasing a new chocolate prototype featuring its Curcugen curcumin ingredient at this year’s Vitafoods Europe.
Image courtesy of DolCas Biotech
DolCas Biotech (Landing, NJ) has announced that it will be showcasing a new chocolate prototype featuring its Curcugen curcumin ingredient at this year’s Vitafoods Europe. This is no easy task, explains DolCas since it requires pairing two astringent ingredients, cocoa and turmeric extract.
“We bring functional chocolate to Switzerland—a country famous for its chocolate—to reinvent the chocolate segment with added better-for-you value,” said Shavon Jackson-Michel, ND, director of medical & scientific affairs for DolCas Biotech, in a press release. “Increased consumer focus on health and wellness continues to drive demand for functional treats. Consumers are seeking convenient ways to incorporate bioactive ingredients into their daily routines, and functional platforms offer a flavorful and accessible option.”
DolCas partnered with a boutique chocolate maker to deliver the ideal chocolate experience. ““The chocolate company successfully addressed the challenges of color and texture and were quite pleased by the mild taste of Curcugen and its ability to readily be applied to the chocolate base,” said K. G. Rao, president of DolCas. “Similarly, we expect customers looking for researched anti-inflammatory and antioxidative actives for other food, beverage, and crossover applications to have an equally great experience with Curcugen.”
Each individually-wrapped 2x2 inch chocolate square will deliver 500 mg of Curcugen. Additionally, the company strengthened its distribution channels and supply chain. “We’ve strengthened our distribution arrangements with IFF which will deepen our foothold in the European market. We have recently opened new offices in Delhi, India and Shanghai, China, strategically positioning ourselves for further expansion and greater efficiency as we pursue our goals for global growth,” explained Rao. “The India and China locations also will serve as sourcing and export houses for DolCas and Orcas ingredient portfolios. The Delhi office will work closely with our raw material production and extraction facilities in Bikanir – where Curcugen is manufactured, to coordinate shipments and distribution globally.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
